米尔维西安,一种用于预防中风的新型XIa因子抑制剂:药理动力学和药理动力学评估
Alessandro Marè1, Arianna Cella1, Yan Tereshko2
1Clinical Neurology, Department of Head, Neck and Neurosciences, Udine University Hospital, Udine, Italy.
Expert opinion on drug metabolism & toxicology
|August 31, 2024
概括
米尔维西安是一种新型XIa因子抑制剂,为心血管和脑血管疾病提供了一个有前途的新型抗凝剂选择. 它在没有增加出血风险的情况下证明了预防血栓事件的有效性,解决了一个关键的临床问题.
科学领域:
- 药理学 药理学是指药理学的学科.
- 心血管医学 心血管医学
- 神经学 神经学
背景情况:
- 抗血小板药和口服抗凝剂是心血管和脑血管疾病的标准治疗方法.
- 目前的抗血栓治疗中,出血风险是一个主要问题,这推动了对更安全替代品的需求.
研究的目的:
- 为了评估milvexian的药理动力学和药理动力学特性.
- 评估milvexian在脑血管疾病中的临床疗效和安全性.
主要方法:
- 药物动力学分析,包括脏排泄和药物相互作用.
- 对患有急性非心血管栓塞性缺血性中风或高风险过渡性缺血性中风的患者的临床疗效的评估.
- 对安全数据的审查,特别是内出血率.
主要成果:
- 米尔韦西安表现出有利的药理动力学,脏排泄率低,药物相互作用最小.
- 在缺血性中风患者中,milvexian与双重抗血小板治疗相结合显示出积极的疗效和安全性,包括低内出血率.
- 目前正在进行的第三期试验正在调查milvexian用于更广泛的中风预防.
结论:
- 米尔维西安通过向XIa.因子来提供一种潜在的更安全的抗凝剂选择.
- 它的药理动力学特征支持在患有功能障碍的患者中使用.
- 临床数据表明在特定的脑血管疾病中有效性和安全性,目前正在进行试验以确认更广泛的实用性.
相关概念视频
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
654
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
654